Cancer cells are abnormal cells that multiply uncontrollably and destroy healthy tissue. Cancer cells are extensively used in research and drug development for various cancer types. The global cancer cell market has witnessed significant growth in recent years due to growing cancer prevalence worldwide and expanding pharmaceutical R&D investments. Cancer cells are used to determine how cancer cells interact, spread or respond to potential treatments. The availability of various cancer cell lines with unique biological properties has further boosted their applications in personalized medicine and precision oncology.
The Global cancer cell market is estimated to be valued at US$ 12440.97 Billion in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the cancer cell market are Honeywell International Inc., Siemens AG, General Electric Company, and Schneider Electric SE. These major players are focusing on expanding their product portfolio and global footprint through mergers and acquisitions.
There are significant opportunities for market players in developing regions due to increasing healthcare investments and growing cancer research activities. Several biotech startups are also emerging which is expected to introduce innovative cancer cell analysis technologies.
The major players are actively pursuing global expansion strategies through collaborations with local research institutes and hospitals. For instance, in 2021, Honeywell International partnered with an Indian hospital to deliver advanced cancer diagnostic solutions. This allows companies to access new markets and provide customized solutions.
Market Drivers
Growing geriatric population susceptible to cancer is a major driver for the cancer cell market. According to WHO, over 60% of new cancer cases and 70% of cancer deaths occur in people above the age of 65 worldwide. This increases the demand for cancer cell research.
Growing collaborations between pharmaceutical companies and research laboratories is another key driver. Pharmaceutical players leverage cancer cells to expedite drug development process and evaluate drug efficacy during pre-clinical trials. This helps in reducing costs and time to market.
Market Restrain
High costs associated with cancer cell culture techniques, media and reagents pose a major challenge, especially for small biotech startups and academic research organizations in developing countries.
Stringent regulatory norms governing the procurement and handling of cancer cell cultures further increase compliance costs. Any non-compliance may also risk clinical research programs. This acts as a restrain.
Segment Analysis
The Global Cancer Cell Market Share can be broadly categorized in lung cancer cell, blood cancer cell, gastrointestinal cancer cell, prostate cancer cell, ovarian cancer cell, breast cancer cell, skin cancer cell, and other cancer cells. Among these, the lung cancer cell dominated the market in 2024 due to high prevalence of lung cancer worldwide. Lung cancer is the leading cause of cancer-related mortality and is responsible for over 1.8 million new cases and 1.6 million deaths annually across the globe. Moreover, smoking-induced lung cancer cases have increased rapidly over the decades, further driving the demand for lung cancer cells in research.
Global Analysis
Geographically, the North America region held the largest share of cancer cell market in 2024 owing to continuous developments in cancer research and biotechnology sector along with rising private and public funding for research activities. Additionally, presence of advanced research infrastructure and prominent biopharmaceutical companies in the US have boosted regional market growth. The Asia Pacific region is estimated to register the fastest growth over the forecast period. This is attributed to rising incidences of cancer, growing healthcare expenditure, increasing government emphasis on research and development activities.
For more insights, Read- https://www.rapidwebwire.com/cancer-cell-market-growth-market-size-share-analysis/
Comments
0 comment